| Optimising Radiation Therapy in Head and Neck Cancers Using Functional Image-Guided Radiotherapy and Novel Biomarkers (NCT04242459) | Royal Marsden NHS Foundation Trust | 2019-10-23 |
| Salivary Gland Autotransplantation for Treatment of XRT Induced Xerostomia (NCT04007081) | University of Wisconsin, Madison | 2019-10-18 |
| Decitabine Treatment in HPV-Induced Anogenital and Head and Neck Cancer Patients After Radiotherapy or as Novel Late Salvage (NCT04252248) | University Hospital Heidelberg | 2019-10-11 |
| A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors (NCT03997968) | Cyteir Therapeutics, Inc. | 2019-10-09 |
| Abemaciclib and Pembrolizumab in Metastatic or Recurrent Head and Neck Cancer (NCT03938337) | University of Alabama at Birmingham | 2019-10-08 |
| Enoblituzumab Plus MGA012 or MGD013 in Squamous Cell Carcinoma of the Head and Neck (NCT04129320) | MacroGenics | 2019-10-01 |
| AMD3100 Plus Pembrolizumab in Immune Checkpoint Blockade Refractory Head and Neck Squamous Cell Carcinoma (NCT04058145) | Massachusetts General Hospital | 2019-09-30 |
| Commensal Oral Microbiota in Head and Neck Cancer (NCT03843554) | University of Pennsylvania | 2019-09-23 |
| Study to Evaluate the Safety of Nanoxel M Inj. (NCT04066335) | Samyang Biopharmaceuticals Corporation | 2019-09-18 |
| Multimodality- Adapted Dose Modification in Head and Neck Cancer Radiation Therapy  (NCT04933357) | National Cancer Institute, Egypt | 2019-09-16 |
| Preservation of Swallowing in Respected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): A Randomized Trial (NCT03997643) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2019-09-06 |
| Effectiveness of a Physical Recovery Program for Head and Neck Cancer Patients (3C-CUIDATE) (NCT04145180) | Universidad de Granada | 2019-09-02 |
| ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) (NCT04044859) | USWM CT, LLC | 2019-08-20 |
| Evaluation of the Automatic Deformable Recontouring on the Daily MVCT for Head and Neck Cancer Adaptive Radiotherapy (NCT03953352) | Institut Claudius Regaud | 2019-08-01 |
| Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head&Neck Cancer (NCT03405142) | Eben Rosenthal | 2019-08-01 |
| A Phase 1 Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (NCT03978689) | Cue Biopharma | 2019-07-30 |
| First-in-human Study of S-588210 (S-488210+S-488211) (NCT04316689) | Shionogi | 2019-07-30 |
| Lymph Drainage Mapping for Tailoring Elective Nodal Irradiation in Head and Neck Cancer (NCT03968679) | The Netherlands Cancer Institute | 2019-07-22 |
| High-risk Recurrent or Second Primary HNSCC With PD-1 Antibody Adjuvant After Salvage Surgery(RePASS) (NCT04126460) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2019-07-10 |
| Preoperative Immune Checkpoint Inhibitor for Patients With Primary Untreated or Recurrent/Metastatic SCCHN (NCT03878979) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-07-08 |
| A Phase 1 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity of AAV2hAQP1 in Subjects With Radiation-Induced Parotid Gland Hypofunction and Xerostomia (NCT04043104) | MeiraGTx UK II Ltd | 2019-06-30 |
| Microvascular Function in Patients Undergoing 5-Fluorouracil Chemotherapy (NCT04042298) | Kansas State University | 2019-06-25 |
| Patient-Reported Outcomes in Head and Neck Cancer (NCT03918382) | Rigshospitalet, Denmark | 2019-06-13 |
| Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy (NCT04106167) | Fate Therapeutics | 2019-06-11 |
| Induction TPN Followed by Nivolumab With Radiation in Locoregionally Advanced Laryngeal and Hypopharyngeal Cancer (NCT03894891) | Dana-Farber Cancer Institute | 2019-06-11 |
| Preoperative Nutritional Intervention in Head and Neck Cancer (NCT03971656) | University of Kansas Medical Center | 2019-06-10 |
| Optimising Microsurgical Reconstruction After Advanced Head and Neck Cancers (NCT04308525) | Rigshospitalet, Denmark | 2019-06-01 |
| Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors (NCT04354064) | Washington University School of Medicine | 2019-05-29 |
| Radiation Therapy (HB-001) by Alpha-particle Sources for Recurrent Malignant Solid Tumors in Japan (NCT04906070) | Hekabio | 2019-05-25 |
| Radiotherapy of Head and Neck Cancer With SIB (NCT06831903) | Wuerzburg University Hospital | 2019-05-21 |
| Feasibility of Patient Selection and Treatment of Head-neck Cancer With Proton Therapy in Denmark (NCT05423704) | Danish Head and Neck Cancer Group | 2019-05-20 |
| Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma (NCT03875716) | Dana-Farber Cancer Institute | 2019-05-20 |
| Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies (NCT03881488) | Compass Therapeutics | 2019-05-17 |
| Effects of Perioperative Immunonutrition in Patients With Head and Neck Cancer (NCT06318221) | TC Erciyes University | 2019-05-01 |
| Pilot Study to Evaluate Photoacoustic Imaging in Head and Neck Cancer (NCT04428515) | Sunnybrook Health Sciences Centre | 2019-04-23 |
| Cetuximab in Head and Neck Cancer Patients (NCT03769311) | University of Wisconsin, Madison | 2019-04-17 |
| PD-L1 ImagiNg to prediCt Durvalumab Treatment Response in HNSCC (NCT03829007) | Radboud University Medical Center | 2019-04-15 |
| NUTRI-HAB - Posttreatment Rehabilitation of Nutrition Impact Symptoms in Head and Neck Cancer Survivors (NCT03909256) | Odense University Hospital | 2019-04-15 |
| MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour (NCT03934827) | Imperial College London | 2019-04-10 |
| Pre-Operative Pregabalin for Post-Operative Pain in Head and Neck Cancer Surgery (NCT03714867) | Augusta University | 2019-03-22 |
| Stellate Ganglion Block in Head and Neck Cancer Surgery (NCT03714906) | Augusta University | 2019-03-22 |
| Nutritional Course of Care After Surgical Treatment at the Patients Affected by a Cancer of the Head and by the Neck (NCT03632200) | Centre Hospitalier Universitaire, Amiens | 2019-03-21 |
| Comparison of Choosing Free ALT or Free PMT for Reconstruction With Head and Neck Cancer (NCT04002713) | Chang Gung Memorial Hospital | 2019-03-20 |
| Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck (NCT03708224) | Alain Algazi | 2019-03-08 |
| Risk for Subsequent Osteoradionecrosis in A Transferred Fibula Flap in Head and Neck Cancer Patients Undergoing Segmental Mandibulectomy: a Cohort Study (NCT06428994) | Chang Gung Memorial Hospital | 2019-03-01 |
| Low-Level Laser in Treatment of Head and Neck Lymphedema: A Pilot Study (NCT03738332) | University of Pennsylvania | 2019-02-25 |
| FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors (NCT03841110) | Fate Therapeutics | 2019-02-15 |
| The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study (NCT04075305) | UMC Utrecht | 2019-02-01 |
| Radiation Oncology Mobile Application (NCT03707860) | King Hussein Cancer Center | 2019-02-01 |
| Transdisciplinary Oral/Oropharyngeal Cancer Research & Care in Head and Neck Cancer (TORCH) (NCT03735745) | Medical University of South Carolina | 2019-01-28 |
| Head and Neck Cancer in Children: A Retrospective Study (NCT02557048) | Assiut University | 2019-01-10 |
| Digital Patient Education Platform in Head and Neck Cancer (NCT05211778) | University of British Columbia | 2019-01-08 |
| Targeting the Tumor Microenvironment in R/M SCCHN (NCT03844763) | Gruppo Oncologico del Nord-Ovest | 2019-01-07 |
| Oral Cancer With Wide Excision and Free Flap Reconstruction (NCT03776578) | National Taiwan University Hospital | 2019-01-01 |
| Prognostic Significance of Lymph Node Yield and Lymph Node Ratio Prospective Observational Study (NCT03534778) | University of Roma La Sapienza | 2019-01-01 |
| Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment. (NCT03992664) | Cyprus University of Technology | 2019-01-01 |
| Temporally Feathered Radiation Therapy (TFRT) for Head and Neck Squamous Cell Carcinoma (NCT03768856) | Case Comprehensive Cancer Center | 2018-12-07 |
| Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients (NCT03787056) | Hospices Civils de Lyon | 2018-12-04 |
| Post-radiation Dental Disease Amongst Head and Neck Cancer Patients (NCT03703648) | Belfast Health and Social Care Trust | 2018-12-01 |
| Dose Painting of Head and Neck Cancer (NCT03847480) | Oslo University Hospital | 2018-12-01 |
| Brief and Intensive Therapy for Dysphagia in Patients With Head and Neck Cancer (NCT03755921) | Federal University of Health Science of Porto Alegre | 2018-12-01 |
| Feasibility Study of a Nurse Intervention to Impact Mucositis Severity and Prevent Dehydration (NCT03416582) | University of Miami | 2018-11-29 |
| Safety and Efficacy of SCT200 in Head and Neck Squamous Cell Carcinoma (NCT03713372) | Sinocelltech Ltd. | 2018-11-28 |
| A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China (NCT03565003) | Jacobio Pharmaceuticals Co., Ltd. | 2018-11-20 |
| Use of Multiparametric MRI in the Management of Head and Neck Cancer: a Prospective Analysis (NCT03993665) | AZ Sint-Jan AV | 2018-11-20 |
| Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors (NCT03755739) | Second Affiliated Hospital of Guangzhou Medical University | 2018-11-01 |
| Pseudo-Simultaneous Imaging of Tumor Hypoxia and Proliferation in HNC Patients Using PET/CT (NCT03548727) | Weill Medical College of Cornell University | 2018-11-01 |
| Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT03691714) | Trisha Wise-Draper | 2018-10-23 |
| Trial of Ibrutinib Combined With Nivolumab or Cetuximab to Treat Recurrent/Metastatic HNSCC (NCT03646461) | University of California, San Diego | 2018-10-17 |
| Apatinib Combined With S-1 for the Treatment of Recurrent/Metastatic Head and Neck Malignancies (NCT03654612) | China International Medical Foundation | 2018-10-16 |
| Effect of Guided Imagery for Radiotherapy-Related Distress in Patients With Head and Neck Cancer (NCT03662698) | University of Colorado, Denver | 2018-10-12 |
| Clinical Impact of Respiratory-Swallow Training on Refractory Dysphagia in Oropharyngeal Head and Neck Cancer (NCT03377270) | VA Office of Research and Development | 2018-10-01 |
| Randomized Controlled Trial of a E-intervention to Help Patients Newly Diagnosed With Cancer Cope Better: Pilot Study (NCT03651570) | Jewish General Hospital | 2018-09-25 |
| Outcomes of Prophylactic Swallowing Therapy in Patients Undergoing Definitive Chemoradiation for Head and Neck Cancer (NCT03435471) | University of Miami | 2018-09-17 |
| FALCOn (Facteur AnthropoLogique Cancer Orl) (NCT03663985) | Institut Claudius Regaud | 2018-09-15 |
| The SEA CHANGE Study: A Self Management Intervention for Head and Neck Cancer Survivors (NCT04051697) | Dublin City University | 2018-09-10 |
| A Study of Epacadostat + Pembrolizumab in Head and Neck Cancer Patients, Who Failed Prior PD-1/PD-L1 Therapy (NCT03238638) | University of Chicago | 2018-09-01 |
| Oxygen Enhanced MRI Measurement in Head and Neck Cancer: Validation and Efficacy of Response. (NCT03646747) | Sally Falk | 2018-09-01 |
| Continous Popliteal Block for Microvascular Free Flap Reconstruction in Ear, Nose and Throat Surgery (NCT03607227) | Region Skane | 2018-09-01 |
| Gustatory Function Following Radiotherapy to the Head and Neck (NCT03738657) | Royal Marsden NHS Foundation Trust | 2018-08-29 |
| Study of Nivolumab Alone or in Combination With Ipilimumab as Immunotherapy vs Standard Follow-up in Surgical Resectable HNSCC After Adjuvant Therapy (NCT03700905) | Universitätsklinikum Hamburg-Eppendorf | 2018-08-21 |
| Imaging With a PET Agent for Detection of Cancers of the Head and Neck (NCT03631017) | Memorial Sloan Kettering Cancer Center | 2018-08-10 |
| Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer (NCT03268993) | University of Pittsburgh | 2018-07-27 |
| Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma (NCT03336606) | Providence Health & Services | 2018-07-25 |
| EACH: Evaluating Avelumab in Combination With Cetuximab in Head and Neck Cancer (NCT03494322) | University College, London | 2018-07-20 |
| Study of Proton SBRT and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer (NCT03539198) | Mayo Clinic | 2018-07-03 |
| CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2) (NCT03504488) | BioAtla, Inc. | 2018-06-27 |
| Effects of Probiotics in Preventing Oral Mucositis (NCT03552458) | National University Hospital, Singapore | 2018-06-26 |
| PaRTNer: Patient Reported Outcomes and Financial Toxicity in Head and Neck Cancer A Pilot, Survey Based Study (NCT03506451) | Duke University | 2018-06-19 |
| PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL (NCT03543813) | CytomX Therapeutics | 2018-06-15 |
| Metformin in Head and Neck Squamous Cell Carcinoma: Effect on Tissue Oxygenation (NCT03510390) | Insel Gruppe AG, University Hospital Bern | 2018-06-13 |
| Self-Care for Head and Neck Cancer Survivors With Lymphedema and Fibrosis (NCT03030859) | University of Pennsylvania | 2018-06-01 |
| Radiotherapy Concurrent With Apatinib in Advanced Soft Tissue and Bone Sarcomas of Head and Neck--RASS Study (NCT03539172) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2018-06-01 |
| Medical Cannabis During Chemoradiation for Head and Neck Cancer (NCT03431363) | Albert Einstein College of Medicine | 2018-05-18 |
| Pre- and Postoperative Nutrition in Head and Neck Cancer Patients (NCT03531190) | University of Copenhagen | 2018-05-10 |
| Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac (NCT04172753) | University Hospital Tuebingen | 2018-05-09 |
| Everolimus in Restoring Salivary Gland Function in Participants With Locally Advanced Head and Neck Cancer Treated With Radiation Therapy (NCT03578432) | University of Arizona | 2018-05-04 |
| Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma (NCT03524326) | Memorial Sloan Kettering Cancer Center | 2018-04-30 |
| A First in Human, Dose Escalation Study of JAB-3068 （SHP2 Inhibitor） in Adult Patients With Advanced Solid Tumors (NCT03518554) | Jacobio Pharmaceuticals Co., Ltd. | 2018-04-23 |
| MucoLox Formulation to Mitigate Mucositis Symptoms in Head/Neck Cancer (NCT03461354) | Wake Forest University Health Sciences | 2018-04-09 |